<DOC>
	<DOC>NCT02219477</DOC>
	<brief_summary>A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin in Adults with Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>1. HCV Genotype 1(GT1) or Genotype 4 (GT4)infection defined as: Positive for antiHCV Ab, HCV RNA &gt; 1,000 IU/mL and laboratory result indicating HCV GT1 infection at Screening. 2. Evidence of cirrhosis by prior liver biopsy, FibroScan or by radiograph (i.e., CT or MRI). 3. ChildPugh Score 7 9 inclusive at time of Screening. 1. Women who are pregnant or breastfeeding. 2. Positive test result for Hepatitis B surface antigen (HbsAg) or antiHIV antibodies (HIV Ab). 3. Prior or current use of any other investigational or commercially available antiHCV agents other than interferon/RBV and/or pegylated interferon (pegIFN)/RBV (including but not limited to telaprevir, boceprevir, sofosbuvir and simeprevir). 4. Confirmed presence of hepatocellular carcinoma indicated on imaging techniques such as computed tomography (CT) scan or magnetic resonance imaging (MRI) within 3 months prior to Screening or on an ultrasound performed at Screening (a positive ultrasound result will be confirmed with CT scan or MRI). 5. Any current or past evidence of ChildPugh C classification.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Decompensated Cirrhosis</keyword>
	<keyword>Interferon-Free</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Child-Pugh B</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Hepatitis C Genotype 4</keyword>
</DOC>